Berylliosis, also known as chronic berylliosis, is related to pulmonary sarcoidosis and sarcoidosis 1. An important gene associated with Berylliosis is HLA-DPB1 (Major Histocompatibility Complex, Class II, DP Beta 1), and among its related pathways/superpathways are Cytokine Signaling in Immune system and Antiviral mechanism by IFN-stimulated genes. The drugs Mesalazine and Infliximab have been mentioned in the context of this disorder. Affiliated tissues include lung and skin, and related phenotypes are immunologic hypersensitivity and abnormal respiratory system physiology